Quantitative comparisons revealed higher expression in malignant tumor cells, CD8+ T cells, and macrophages/monocytes, indicating a broad cellular expression pattern and suggesting that HSP90AA1 may contribute to UVM progression by modulating diverse cell populations within the TME. Here, CD8A is linked to cancer.